Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1007-1011

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damiano, P. F.
Right arrow Articles by Ignacio J. de la Riva ;
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damiano, P. F.
Right arrow Articles by Ignacio J. de la Riva ;,
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FRUCTOSE
*GLYCERIN
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1999;34:1007-1011.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Potential Role of Glycerol Leading to Rat Fructose Hypertension

Pablo F. Damiano; María I. Rosón; Inés Armando; Susana Nowicki; Eduardo Dascal; Luis Cuniberti; Liliana E. Albornoz; Ignacio J. de la Riva ;

From the Department of Physiology, School of Medicine, Buenos Aires University (P.F.D., M.I.R., L.E.A., I.J.d.l.R.); Center for Endocrinological Research, R. Gutierrez Pediatric Hospital (I.A., S.N., E.D.); Austral University (S.N.); and Favaloro University (L.C.), Buenos Aires, Argentina.

Correspondence to Dr Ignacio J. de la Riva, Depto de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155. 7mo Piso, (1121) Buenos Aires, Argentina. E-mail idelariv{at}fmed.uba.ar


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—A fructose-enriched diet promotes hypertension in rats. We thought that an enhancement of the glycolytic and/or lipid disorder (s) that raise blood pressure could be the cause. Therefore, we studied 4 groups of Sprague-Dawley rats (±200 g): (1) control rats received a standard diet and tap water; (2) the glycerol group of rats received a standard diet and 0.54 mol/L glycerol in tap water; (3) the fructose group was given a fructose-enhanced diet (chow had 55% fructose instead of dextrin) and tap water; and (4) the fructose-glycerol group was given the fructose-enhanced diet and 0.54 mol/L glycerol in drinking water. At the end of the second week, the findings were as follows. Blood pressure was 149±2 mm Hg in the fructose-glycerol group versus 129±2 (P<0.001), 131±2 (P<0.001), and 140±3 (P<0.005) mm Hg in the control, glycerol, and fructose groups, respectively. Insulinemia was higher in the fructose-glycerol group than the control (P<0.001), glycerol (P<0.001), and fructose groups (P<0.001); triglyceridemia was higher in the fructose-glycerol (P<0.02), fructose (P<0.05), and glycerol groups (P<0.02) than the control group. Thoracic aorta rings showed a lower ED50 to 12,13-phorbol dibutyrate in the fructose-glycerol group than in the control (P<0.001), glycerol (P<0.002), and fructose groups (P<0.001). In conclusion, glycerol-fructose administration resulted in hypertriglyceridemia, hyperinsulinemia, and increased vascular sensitivity to 12,13-phorbol dibutyrate (with respect to the control group), and significantly greater expression of protein kinase C {alpha} and ßII (with respect to the glycerol group).


Key Words: fructose • hypertension • insulin • glycerol • triglycerides


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In experimental animals, fructose overload can raise blood pressure (BP) and cause hypertriglyceridemia, hyperinsulinemia, impaired glucose tolerance, and insulin resistance in several target tissues.1 2 3 4 5 In this regard, many investigators have suggested that increased insulin levels and/or resistance may be causally related to elevated BP.6 7 This possibility is supported by reports correlating hyperinsulinemia with hypertension.1 8 However, hyperinsulinemia and hypertension have been described as independent factors by other authors.7 9 Consequently, the underlying mechanisms of these 2 conditions are, as yet, undefined.

The lipid dysmetabolism that accompanies fructose overload is another possible cause of hyperinsulinemia and hypertension. In fact, a vicious cycle between hypertriglyceridemia and insulin resistance exists.10 Prentki and Corkey11 studied type II diabetes mellitus and proposed that hyperinsulinemia could be explained by alterations in the glycolytic pathway and lipid metabolism (hypertriglyceridemia is one of the features of a lipid disorder). This metabolic abnormality is followed by an increase of long-chain acyl coenzyme A, which results in an elevation of insulin secretion. The hypertriglyceridemia associated with fructose overload seems to result from lower plasma extrahepatic triglyceride lipase activity and greater VLDL-triglyceride secretion rates.12 Similarly, increased levels of glycerol in the diet induce hypertriglyceridemia in the rat as a result of lower triglyceride clearance after decreased lipoprotein lipase activity.13 Lee et al14 found that raised levels of glucose increase diacylglycerol, which in turn activates protein kinase C (PKC) in the cultured vascular cells and in the aorta, heart, and other tissues from streptozotocin-diabetic rats15 16 17 ; PKC can also modulate contractions of vascular smooth-muscle cells.18 19 The liver and kidneys, which are formally recognized as the main organs responsible for glycerol metabolism (which leads to glyconeogenesis), account for less than 50% of endogenous glycerol clearance.20 This finding indicates that other tissues (putatively including the vascular tissue) that contain glycerol kinase in low concentrations may participate in its metabolism and, thus, potentiate diacylglycerol synthesis.

Accordingly, the objective of this study was to observe the effect of glycerol supplementation on BP to determine to what extent lipid and/or glycolytic pathways are primarily involved in fructose-caused hypertension.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Male Sprague-Dawley rats (Animal Facilities, Biochemistry College, Buenos Aires University) that weighed 180 to 230 g at the start of the study were used. Animals were maintained in a room at 22±2°C, and the air was adequately recycled. Initially, all rats were fed a commercial standard laboratory chow (Asociación Cooperativas Argentinas) with the following composition (wt/wt): 20% proteins, 3% fat, 2% fiber, 6% minerals, and 69% starch and vitamin supplements. After 2 weeks, animals were identified by ear marks and randomly divided into 4 groups: (1) the control group continued on the standard diet and was given tap water to drink; (2) the glycerol group received the same solid diet and a glycerol solution (0.54 mol/L) was added to the tap water; (3) the fructose group received a special diet containing 14% starch and 55% fructose, instead of the 69% starch of the standard diet, and tap water to drink; and (4) the fructose-glycerol group received the same diet as group 3 and the 0.54 mol/L glycerol solution to drink. All groups were examined after 14 days.

BP and Body Weight Measurement
Rats were acclimated to the procedure of BP measurement at 1.00 PM twice a week starting 1 week before dietary manipulation and continuing through the experimental period. Indirect systolic BP was determined as previously reported.21 The mean of 3 consecutive stable readings was used as the measurement of the systolic BP of each rat for that day, and the average BP of the last 2 readings (11th and 13th days of the study) were used for statistical comparisons. The procedure for analyzing the BP data was similar to that reported by Hwang et al.1 In addition, rats were weighed before dietary manipulation and at the end of the study.

Plasma Assays
Animals fasted for 5 hours and then were anesthetized with an intraperitoneal injection of pentobarbital (60 mg/kg body weight); 90 minutes later, blood samples were drawn from the retro-ocular plexus. The samples were immediately centrifuged and frozen at -20°C until assayed for glucose, triglycerides, and insulin. Glucose (Kit Winner Glycemia HK, UV) and triglyceride (Boehringer Mannheim GPO-PAP, enzymatic method kit) levels were measured by spectrophotometric methods (Automatic Analyzer, Abbott Spectrum CCX). Insulin was determined in plasma samples by radioimmunoassay using the method of Herbert et al.22

Catecholamines in the Artery Wall
The catechols in tissue homogenates from the abdominal aorta were determined by high-pressure liquid chromatography with electrochemical detection, as reported previously.23

PKC Western Blots in the Artery Wall
Descendent thoracic rat aorta segments were removed and homogenized in 0.3 mL of ice-cold homogenization buffer. PKC{alpha}, ßII, and {epsilon} were determined by immunoblotting, as previously described.24 One sample from each of the 4 rat groups was processed in parallel in each gel. The autoradiograms were quantified by densitometric scanning. Values from the treated animals were expressed as percentages of a single control value.

Contractility of Aorta Rings
Batches of 4 rats (1 from each group) were killed daily by decapitation. The thoracic aorta was harvested, placed into cold Krebs solution, and prepared for contractility recording, as previously reported.21 Thereafter, the effect of 10-5 mol/L nitroprusside on baseline ring tension was observed. In other groups of rings, the dose response to 12,13-phorbol dibutyrate (PDBu; 5 · 10-8 to 5 · 10-6 mol/L) was determined.

Statistical Analysis
Results are expressed as mean±SEM, and the significance level was P<0.05. Comparisons of data between different groups were made by 1-way ANOVA followed by a Newman-Keuls post hoc test when significance was indicated.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Effect of Fructose and Glycerol on Arterial Pressure
After 14 days of experimental intervention, BP was as follows (mm Hg): control, 129±2; glycerol, 131±2; fructose, 140±3; and fructose-glycerol, 149±2. Significant differences were observed for the fructose group versus control (P<0.005) and glycerol groups (P<0.005) and for the fructose-glycerol group versus control (P<0.001), glycerol (P<0.001), and fructose groups (P<0.005) (Figure 1).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 1. BP in control (C), glycerol (G), fructose (F), and fructose-glycerol (FG) groups. *'**Groups against which significantly different values were found.

Fasting Glycemia, Triglyceridemia, and Insulinemia
On day 14, glycemia values for the glycerol, fructose, and fructose-glycerol groups were not significantly different from the control group. However, the glycemia concentration was significantly lower in the fructose-glycerol rats when compared with the fructose rats (P<0.05). Plasma triglyceride concentrations increased significantly with respect to the control group in all treated groups. Plasma insulin concentrations were significantly different from all other groups only in fructose-glycerol rats (Figure 2).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Glycemia, triglyceridemia, and insulinemia in control (C), glycerol (G), fructose (F), and fructose-glycerol (FG) groups; *Group against which significantly different values were found.

Vascular Contractility
No change in basal tone was discovered by the administration of 10-5 mol/L nitroprusside. However, dose-response curves with PDBu showed a significantly lower ED50 (higher sensitivity) in aorta rings from the fructose-glycerol group with respect to those from the control (P<0.001), glycerol (P<0.002), and fructose (P<0.001) groups. Maximum tension was significantly higher only in the fructose group (Figure 3).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Left, Dose-response curves to PDBu in control (C), glycerol (G), fructose (F), and fructose-glycerol (FG) groups. *Fructose-glycerol group was significantly different than control(P<0.005), glycerol (P<0.001) , or fructose groups (P<0.005). {dagger}Significant differences versus control (glycerol, P<0.05; fructose, P<0.05; and fructose-glycerol, P<0.02). {ddagger}Responses of fructose-glycerol (P<0.05) and glycerol groups (P<0.05) were significantly different than those of fructose group. §Responses from fructose-glycerol (P<0.05) and glycerol groups (P<0.05) were significantly different than those of fructose group. Right, ED50 of PDBu expressed as -log mol/L (Mean±SEM). *Fructose-glycerol group was significantly different from the other groups.

Catecholamines in the Artery Wall
No significant differences were observed among groups; nevertheless, with the exception of dopamine in the fructose group, all mean values were lower than in the control group (Table).


View this table:
[in this window]
[in a new window]
 
Table 1. Catecholamines and DHPG in Homogenates of the Thoracic Aorta

PKC Western Blot in Artery Wall
PKC{alpha} expression was significantly lower in the glycerol group than the control and fructose-glycerol groups, and PKCßII expression was significantly lower in the glycerol group than the fructose-glycerol group. No significant changes in PKC{epsilon} were detected between groups (Figure 4).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 4. Densitometric quantification of PKC{alpha}, PKCßII, and PKC{epsilon} expression in thoracic aorta. Representative Western blots of each isoenzyme are shown in inserts. C indicates control; G, glycerol; F, fructose; and FG, fructose-glycerol.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Although diabetes has been thoroughly investigated at the clinical and experimental levels, little attention has been paid to prior metabolic disorders and hypertension, which may ensue from excessive carbohydrate intake. The experimental model studied here is currently under intensive research; it mimics the risk factors of sweet-toothed subjects in the general population, ranging from "resistant" to "prediabetic" individuals.

Cardiac output is reportedly within normal limits in the fructose-overload experimental model1 ; thus, peripheral vascular resistance must be increased to account for a high BP. Therefore, in addition to general metabolic disorders, this article examines some factors concerning the target organ, ie, the vascular wall. Glycerol supplementation was done to enhance the metabolic disorders leading to hypertension.

Peral de Bruno et al25 reported that aorta rings from rats after 10 weeks of a fructose diet have an increased basal tone, as shown by the presence of a relaxing effect to 10-5 mol/L nitroprusside. In contrast, the present experiments failed to disclose changes in basal tone by nitroprusside in vitro after 2 weeks of fructose overload. Sensitivity to PDBu stimulation was significantly greater in vessels from our fructose-glycerol rats (Figure 3), although at a concentration of 7.27 · 10-7 mol/L, both the glycerol and fructose groups showed significantly greater vascular responses than controls. Such findings agree with the raised BP (putatively in peripheral resistance) that developed after 2 weeks both in the fructose and fructose-glycerol groups. Moreover, results from the fructose-glycerol group in particular support the potential effect of glycerol; BP, insulinemia, and vascular sensitivity to PDBu were all significantly greater when fructose was supplemented with 0.54 mol/L glycerol in drinking water.

The maximal tension to PDBu that developed was lower in the fructose-glycerol and glycerol groups and higher in the fructose group when compared with controls. This prompted us to investigate whether the different maximal responses to the direct PKC activator PDBu correlated with a different expression of PKC in the thoracic aorta within the studied groups. However, only in the glycerol group did a direct relationship between changes in the maximal PDBu-induced response and PKC expression exist.

Concerning catecholamines, an increased systemic sympathetic tone has been reported in fructose-overloaded rats.26 27 In this regard, although not significantly different among groups, all mean values in the aorta wall were lower in glycerol-supplemented groups (Table); these results render the increase in local catecholamine content in these groups unlikely. This suggestion is of particular interest for the fructose-glycerol rats in view of their greater incidence of hypertension.

In conclusion, our results showed the following: (1) oral glycerol administration per se (glycerol group) was accompanied by hypertriglyceridemia (as high as in other groups), normal insulinemia, and decreased thoracic aorta PKC{alpha} expression; (2) in the fructose group, hypertriglyceridemia was again present, but rats failed to show hyperinsulinemia; (3) when glycerol was administered with fructose (fructose-glycerol group), hypertriglyceridemia, hyperinsulinemia, increased vascular sensitivity to PDBu, and significantly greater values of PKC{alpha} and ßII expression with respect to the glycerol group were simultaneously present and accompanied by greater BP values with respect to the other 3 experimental groups. However, the mechanism linking glycerol potentiation to fructose overload remains unclear.


*    Acknowledgments
 
This work was supported by grants from the National Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET]) and the University of Buenos Aires, Argentina. Drs Armando, PhD, Norwicki, PhD, and de la Riva, PhD, are senior investigators from CONICET, Argentina.

Received May 17, 1999; first decision June 15, 1999; accepted July 14, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Hwang I-S, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512–516.[Abstract/Free Full Text]

2. Buña RD, Tomita T, Sasaki S. Chronic sucrose ingestion induces mild hypertension and tachycardia in rats. Hypertension. 1983;5:218–225.[Abstract/Free Full Text]

3. Preuss HG, El Zein M, Knapka J, MacArthy P, Yousufi AK, Gleim GW, Glace B, Zukowska-Grojec Z. Blood pressure responses to sucrose ingestion in four rats strains. Am J Hypertens. 1992;5:244–250.[Medline] [Order article via Infotrieve]

4. Hulman S, Falkner B. The effect of dietary sucrose on growth, blood pressure, and metabolism in developing Sprague-Dawley rats. Pediatr Res. 1994;36:95–101.[Medline] [Order article via Infotrieve]

5. Chicco A, Soria A, Fainstein-Day P, Gutman R, Lombardo YB. Multiphasic metabolic changes in the heart of rats fed a sucrose-rich diet. Horm Metab Res. 1994;26:397–403.[Medline] [Order article via Infotrieve]

6. Heise T, Magnusson T, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension. 1998;32:243–248.[Abstract/Free Full Text]

7. Tsuruta M, Hashimoto R, Adachi H, Imaizumi T, Nomura G. Hyperinsulinemia as a predictor of hypertension: an 11-year follow-up study in Japan. J Hypertens. 1996;14:483–488.[Medline] [Order article via Infotrieve]

8. Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med. 1986;80:861–864.[Medline] [Order article via Infotrieve]

9. Masuo K, Mikami H, Ogihara T, Tuck ML. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension. 1998;32:96–100.[Abstract/Free Full Text]

10. Steiner G, Vranic M. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Int J Obes. 1982;6(suppl 1):117–124.

11. Prentki M, Corkey BE. Are the ß-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes. 1996;45:273–283.[Abstract]

12. Chicco A, Bernal C, Soria A, Giangrossi G, Lombardo Y. Dietary effect of partial or total substitution of sucrose for starch on glucose and lipid metabolism in dyslipidemic rats. Nutr Res. In press.

13. Abe R, Macdonald I, Maruhama Y, Goto Y. Effect of glycerol on triglyceride metabolism in the rat. Metabolism. 1979;28:97–99.[Medline] [Order article via Infotrieve]

14. Lee T-S, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A. 1989;86:5141–5145.[Abstract/Free Full Text]

15. King GL, Ishii H, Koya D. Diabetic vascular dysfunction: a model of excessive activation of protein kinase C. Kidney Int. 1997; 52(suppl 60):S77–S85.

16. King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes. 1996; 45(suppl 3):S105–S108.

17. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet. 1997; 350(suppl 1):9–13.

18. Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol. 1994;267: C669–C678.

19. Hirata K-I, Kuroda R, Sakoda T, Katayama M, Inoue N, Suematsu M, Kawashima S, Yokoyama M. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension. 1995;25:180–185.[Abstract/Free Full Text]

20. Previs S, Martin S, Hazey J, Soloviev M, Keating A, Lucas D, David F, Koshy J, Kirschembaum D, Tserng K, Brunengraber H. Contributions of liver and kidneys to glycerol production and utilization in the dog. Am J Physiol. 1996;271: E1118–E1124.

21. Puyó AM, Vega GW, Pellegrino de Iraldi A, Albornoz LE, Rosón MI, Scaglia P, Celentano MM, Corazza JP, Palumbo EL, Fernández BE, de la Riva IJ. Atrial natriuretic factor in two kidney-two clip renovascular hypertension in the rat. Medicina (B Aires). 1998;58:165–170.[Medline] [Order article via Infotrieve]

22. Herbert V, Lan KS, Gottieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965;25:1375–1384.[Abstract/Free Full Text]

23. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid chromatography determination of 3,4-dihydroxyphenylglycol, catecholamines and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030–2033.[Abstract/Free Full Text]

24. Nowicki S, Chen SL, Aizman O, Cheng XJ, Li D, Nowicki C, Nairn A, Greengard P, Aperia A. 20-hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C: role in regulation of rat renal Na+, K+-ATPase. J Clin Invest. 1997;99:1224–1230.[Medline] [Order article via Infotrieve]

25. Peral de Bruno M, Alonso C, Proto M, Rondon J, Coviello A. La hipertension inducida en ratas por una dieta cronica de fructosa modifica la reactividad vascular aumentando el tono basal. Presented at the 5th Congreso Argentino de Hipertension Arterial, 1997. Tucumán Argentina, 20–22 November 1997. TL020. Abstract.

26. Masuo K, Mikami H, Ogihara T, Tuck ML. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension. 1998;32:96–100.

27. Kaufman LN, Peterson MM, Smith SM. Hypertension and sympathetic hyperactivity induced in rat by high-fat or glucose diet. Am J Physiol. 1991;260:E95–E100.[Abstract/Free Full Text]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damiano, P. F.
Right arrow Articles by Ignacio J. de la Riva ;
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damiano, P. F.
Right arrow Articles by Ignacio J. de la Riva ;,
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FRUCTOSE
*GLYCERIN
Medline Plus Health Information
*High Blood Pressure